Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMED10 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | ATP5E | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | ASCL4 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | AK9 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | CSRNP2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | ZFYVE9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | PRDX6 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | MUCL1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | TBC1D14 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | ZNF564 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |